Life Sciences Summit Maps Out Next-Generation Medicines

Medical Center & Health Care

Life Sciences Summit Maps Out Next-Generation Medicines
National Symposium Showcases Innovation, Promotes Science/Industry Collaboration

STONY BROOK, N.Y., October 17, 2011 – The Center for Biotechnology at Stony Brook University, in collaboration with Demy-Colton Life Science Advisors, and key opinion leaders from the biotech and biopharmaceutical industries, academia, medical research foundations, and investment community, has organized a two-day event to forge partnerships to accelerate the development of new treatments for some of the world’s most devastating diseases affecting millions. The Life Sciences Summit  is the only national translational science partnering event that brings these groups together to map out commercialization strategies for next-generation medicines. The event takes place at Sentry Centers Midtown East in New York City on November 16-17, 2011.
Event co-hosts include Stony Brook University, Cold Spring Harbor Laboratory, and Brookhaven National Laboratory. The program features more than 150 internationally recognized speakers, including presentations by pharmaceutical company executives, venture capitalists, and nationally recognized physician and academic leaders. Attendees will engage in interactive symposia, workshops, and partnering sessions focused on biomedical solutions in the fields of infectious diseases, neuroscience, oncology, and regenerative medicine. Dozens of new companies will showcase their business platforms featuring breakthrough technologies emerging from leading academic institutions worldwide that have the potential to transform the industry and human healthcare.
“All of the companies and technologies that will be presented have the potential to make significant contributions to the next generation of medical products that could help to transform therapies for many illnesses,” says Diane Fabel, Executive Director, Life Sciences Summit, and Director of Operations, Center for Biotechnology. “The concentration of intellect, creativity, and innovation at the event creates a dynamic atmosphere that fosters opportunities for collaborations, new business, and new dialogue focused on the future of the biotechnology industry.”

Fabel adds that leading executives from the world’s most prestigious and prolific biomedical research institutions, along with leaders from ...

Read More